Show simple item record

dc.contributor.authorRodrigo, Gustavo J
dc.contributor.authorPrice, David B
dc.contributor.authorAnzueto, Antonio
dc.contributor.authorSingh, Dave
dc.contributor.authorAltman, Pablo
dc.contributor.authorBader, Giovanni
dc.contributor.authorPatalano, Francesco
dc.contributor.authorFogel, Robert
dc.contributor.authorKostikas, Konstantinos
dc.date.accessioned2017-03-20T09:28:20Z
dc.date.available2017-03-20T09:28:20Z
dc.date.issued2017-03-17
dc.identifier.citationRodrigo , G J , Price , D B , Anzueto , A , Singh , D , Altman , P , Bader , G , Patalano , F , Fogel , R & Kostikas , K 2017 , ' LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD : a systematic review and meta-analysis ' International journal of chronic obstructive pulmonary disease , vol 12 , pp. 907—922 . DOI: 10.2147/COPD.S130482en
dc.identifier.issn1176-9106
dc.identifier.otherPURE: 95907295
dc.identifier.otherPURE UUID: 458b761c-058a-41aa-8d9c-bbcad3c6d21a
dc.identifier.otherScopus: 85016136622
dc.identifier.urihttp://hdl.handle.net/2164/8355
dc.descriptionAcknowledgments The meta-analysis work was performed by Guruprasad Rao KS and Sharanbasappa Durg of Molecular Connections (P) Ltd, Bangalore, India, under the guidance of the manuscript authors and Novartis Pharma AG (Basel, Switzerland). Medical writing assistance was provided by Colette O’Sullivan, PhD, of Scriva Medical Communications Ltd, a professional medical writer funded by Novartis. Development of the manuscript was supported by Novartis Pharma AG (Basel, Switzerland). The authors received no compensation related to the development of the manuscript.en
dc.format.extent16en
dc.language.isoeng
dc.relation.ispartofInternational journal of chronic obstructive pulmonary diseaseen
dc.rightsThis work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms. https://creativecommons.org/licenses/by-nc/3.0/en
dc.subjectLABA/LAMA combinationsen
dc.subjectCOPDen
dc.subjectLAMAen
dc.subjectLABA/ICSen
dc.subjectmeta-analysisen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleLABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD : a systematic review and meta-analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Medicine, Medical Sciences & Nutrition, Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttp://dx.doi.org/10.2147/COPD.S130482


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record